We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
+13.36%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$9.1B
AUM Growth
+$1.09B
Cap. Flow
+$60.9M
Cap. Flow %
0.67%
Top 10 Hldgs %
45.34%
Holding
89
New
10
Increased
23
Reduced
45
Closed
5

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$139M
2
NVDA icon
NVIDIA
NVDA
+$113M
3
AMT icon
American Tower
AMT
+$59.5M
4
TTEK icon
Tetra Tech
TTEK
+$30.2M
5
AMZN icon
Amazon
AMZN
+$29.7M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$74.1M
2
ILMN icon
Illumina
ILMN
+$58.5M
3
CME icon
CME Group
CME
+$49.8M
4
MRK icon
Merck
MRK
+$45.6M
5
DIS icon
Walt Disney
DIS
+$36.2M

Sector Composition

Rank Sector Weight
1 Technology 22.27%
2 Financials 14%
3 Healthcare 12.16%
4 Consumer Discretionary 11.82%
5 Industrials 11.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCI icon
26
Service Corp International
SCI
$11.7B
$150M 1.65%
2,188,400
-78,429
-3% -$4.72M
LLY icon
27
Eli Lilly
LLY
$1.03T
$144M 1.59%
247,489
+237,478
+2,372% +$139M
ACWI icon
28
iShares MSCI ACWI ETF
ACWI
$32.7B
$140M 1.54%
1,379,605
+1,563
+0.1% +$150K
NOW icon
29
ServiceNow
NOW
$114B
$137M 1.51%
973,050
-39,660
-4% -$5M
MIDD icon
30
Middleby
MIDD
$6.03B
$134M 1.48%
913,397
-13,855
-1% -$1.76M
JPM icon
31
JPMorgan Chase
JPM
$933B
$130M 1.43%
766,139
+17,732
+2% +$2.69M
MCO icon
32
Moody's
MCO
$83.5B
$128M 1.4%
326,609
-25,187
-7% -$8.75M
TXN icon
33
Texas Instruments
TXN
$255B
$118M 1.29%
690,425
+190,424
+38% +$29.5M
ARMK icon
34
Aramark
ARMK
$15.1B
$112M 1.23%
3,982,858
-1,174,649
-23% -$31.8M
UPS icon
35
United Parcel Service
UPS
$89.5B
$94.4M 1.04%
600,626
+39,841
+7% +$6.02M
BLK icon
36
Blackrock
BLK
$170B
$50.6M 0.56%
62,287
-562
-0.9% -$392K
BKNG icon
37
Booking.com
BKNG
$150B
$42.1M 0.46%
296,550
-25,950
-8% -$3.24M
ZTS icon
38
Zoetis
ZTS
$31.9B
$40.7M 0.45%
206,195
-33
-0% -$5.84K
PFE icon
39
Pfizer
PFE
$142B
$39.8M 0.44%
1,382,631
+969,973
+235% +$29.3M
EQIX icon
40
Equinix
EQIX
$103B
$27.2M 0.3%
33,756
-67
-0.2% -$51.4K
MELI icon
41
Mercado Libre
MELI
$95.6B
$24.1M 0.27%
+15,366
New +$21.8M
UAA icon
42
Under Armour
UAA
$2.91B
$22.6M 0.25%
2,570,383
FMX icon
43
Fomento Económico Mexicano
FMX
$43.2B
$20.9M 0.23%
160,353
-48,590
-23% -$5.78M
ENTG icon
44
Entegris
ENTG
$17.8B
$20M 0.22%
167,332
-44,955
-21% -$4.56M
EQNR icon
45
Equinor
EQNR
$96.8B
$19.3M 0.21%
610,885
-4,550
-0.7% -$147K
WY icon
46
Weyerhaeuser
WY
$16.9B
$19M 0.21%
545,638
-68,864
-11% -$2.14M
SPLK
47
DELISTED
Splunk Inc
SPLK
$18.6M 0.2%
122,272
-1,560
-1% -$233K
EW icon
48
Edwards Lifesciences
EW
$50B
$17.7M 0.19%
232,216
-39,987
-15% -$2.78M
GOOG icon
49
Alphabet (Google) Class C
GOOG
$4.08T
$16.9M 0.19%
119,929
-135
-0.1% -$18.3K
GLD icon
50
SPDR Gold Trust
GLD
$133B
$14.8M 0.16%
77,658
+509
+0.7% +$93.3K

Similar funds

Sarasin & Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Sarasin & Partners held 89 positions worth $9.1B, up 14% from $8.01B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sarasin & Partners's Q4 2023 filing shows 10 new, 23 increased, 45 reduced and 5 closed positions. Its largest new stake was Mercado Libre: 15,366 shares worth $24.1M. The largest sale was Broadcom, an estimated $74.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Sarasin & Partners's largest Q4 2023 buy was Mercado Libre: 15,366 shares worth $24.1M.
  • Sarasin & Partners added most to Eli Lilly in Q4 2023, an estimated $139M increase.
  • Sarasin & Partners's biggest Q4 2023 reduction was Broadcom, cutting an estimated $74.1M.
  • Sarasin & Partners fully exited Illumina in Q4 2023, selling an estimated $58.5M.
  • Sarasin & Partners's ten largest holdings make up 45% of its $9.1B portfolio in Q4 2023.
  • Sarasin & Partners opened 10 new positions and closed 5 in Q4 2023.
  • Sarasin & Partners's portfolio value rose 14% quarter-over-quarter to $9.1B.

Based on Sarasin & Partners's 13F filing for Q4 2023, filed 10 Jan 2024.